Advertisement
Letter to the Editor| Volume 378, P210-212, July 15, 2017

Expanding the clinical phenotype of CAPN1-associated mutations: A new case with congenital-onset pure spastic paraplegia

  • Lorena Travaglini
    Correspondence
    Corresponding author at: Unit of Neuromuscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Dept Neurosciences, Bambino Gesu' Children's Research Hospital, Polo di Ricerca S. Paolo, V.le S. Paolo, 15, 00146 Rome, Italy.
    Affiliations
    Department of Neurosciences, Unit of Neuromuscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
    Search for articles by this author
  • Emanuele Bellacchio
    Affiliations
    Research Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
    Search for articles by this author
  • Chiara Aiello
    Affiliations
    Department of Neurosciences, Unit of Neuromuscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
    Search for articles by this author
  • Stefano Pro
    Affiliations
    Department of Neurosciences, Unit of Neurology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
    Search for articles by this author
  • Enrico Bertini
    Affiliations
    Department of Neurosciences, Unit of Neuromuscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
    Search for articles by this author
  • Francesco Nicita
    Affiliations
    Department of Neurosciences, Unit of Neuromuscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
    Search for articles by this author
      Calpains are intracellular calcium-dependent cysteine proteases ubiquitously expressed in mammals. CAPN1 encodes calpain-1, one of the major calpain isoforms expressed in the Central Nervous System (CNS) [
      • Baudry M.
      • Simonson L.
      • Dubrin R.
      • Lynch G.
      A comparative study of soluble calcium-dependent proteolytic activity in brain.
      ,
      • Hamakubo T.
      • Kannagi R.
      • Murachi T.
      • Matus A.
      Distribution of calpains I and II in rat brain.
      ]. Growing evidence suggests that calpain-1 is involved in several molecular processes and pathways in the CNS such as synaptic plasticity, neuronal migration, neuronal necrosis and maintenance [
      • Liu J.
      • Liu M.C.
      • Wang K.K.
      Calpain in the CNS: from synaptic function to neurotoxicity.
      ,
      • Wang Y.
      • Briz V.
      • Chishti A.
      • Bi X.
      • Baudry M.
      Distinct roles for mu-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration.
      ,
      • Wang Y.
      • Zhu G.
      • Briz V.
      • Hsu Y.T.
      • Bi X.
      • Baudry M.
      A molecular brake controls the magnitude of long-term potentiation.
      ]. Recently, rare homozygous or compound-heterozygous pathogenic variants in the CAPN1 gene (MIM: 114220) have been reported in eight individuals from three families with an adult-onset (mean age 28.5 years; range 19–39), complicated form of Hereditary Spastic Paraplegia (HSP). In addition to mild-to-moderate spastic paraplegia with slowly progressive course, patients variably presented upper limb hyperreflexia, dysarthria, gait ataxia and sensory axonal neuropathy [
      • Gan-Or Z.
      • Bouslam N.
      • Birouk N.
      • et al.
      Mutations in CAPN1 cause autosomal-recessive hereditary spastic paraplegia.
      ]. Later, Wang and colleagues identified CAPN1 biallelic pathogenic variants in six patients from four families who presented with progressive ataxia and spasticity, with onset at about 20 years [
      • Wang Y.
      • Hersheson J.
      • Lopez D.
      • et al.
      Defects in the CAPN1 Gene result in alterations in cerebellar development and cerebellar ataxia in mice and humans.
      ]; mild-to-moderate cerebellar atrophy was evident on brain MRI in three cases [
      • Wang Y.
      • Hersheson J.
      • Lopez D.
      • et al.
      Defects in the CAPN1 Gene result in alterations in cerebellar development and cerebellar ataxia in mice and humans.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Baudry M.
        • Simonson L.
        • Dubrin R.
        • Lynch G.
        A comparative study of soluble calcium-dependent proteolytic activity in brain.
        J. Neurobiol. 1986; 17: 15-28
        • Hamakubo T.
        • Kannagi R.
        • Murachi T.
        • Matus A.
        Distribution of calpains I and II in rat brain.
        J. Neurosci. 1986; 6: 3103-3111
        • Liu J.
        • Liu M.C.
        • Wang K.K.
        Calpain in the CNS: from synaptic function to neurotoxicity.
        Sci. Signal. 2008; 1: re1
        • Wang Y.
        • Briz V.
        • Chishti A.
        • Bi X.
        • Baudry M.
        Distinct roles for mu-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration.
        J. Neurosci. 2013; 33: 18880-18892
        • Wang Y.
        • Zhu G.
        • Briz V.
        • Hsu Y.T.
        • Bi X.
        • Baudry M.
        A molecular brake controls the magnitude of long-term potentiation.
        Nat. Commun. 2014; 5: 3051
        • Gan-Or Z.
        • Bouslam N.
        • Birouk N.
        • et al.
        Mutations in CAPN1 cause autosomal-recessive hereditary spastic paraplegia.
        Am. J. Hum. Genet. 2016; 98: 1038-1046
        • Wang Y.
        • Hersheson J.
        • Lopez D.
        • et al.
        Defects in the CAPN1 Gene result in alterations in cerebellar development and cerebellar ataxia in mice and humans.
        Cell Rep. 2016; 16: 79-91